Skip to main content
Halle Moore, MD, Oncology, Cleveland, OH

Halle C Moore MD


Physician

Join to View Full Profile
  • 9500 Euclid AveCleveland, OH 44195

  • Phone+1 800-223-2273

Dr. Moore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1996 - 1997
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1993 - 1996
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - Present
  • OH State Medical License
    OH State Medical License 1999 - 2026
  • IL State Medical License
    IL State Medical License 2002 - 2020
  • NY State Medical License
    NY State Medical License 2003 - 2020
  • MI State Medical License
    MI State Medical License 2002 - 2018
  • PA State Medical License
    PA State Medical License 1996 - 2006
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Pondering the RxPONDER StudyDecember 2020

Press Mentions

  • VIDEO: OlympiA Trial Shows Olaparib’s Benefits for Patients with BRCA Mutations ‘Persist’
    VIDEO: OlympiA Trial Shows Olaparib’s Benefits for Patients with BRCA Mutations ‘Persist’December 24th, 2024
  • VIDEO: Risk-Reducing Surgeries Result in ‘Fewer Breast Cancer Events’ for BRCA Carriers
    VIDEO: Risk-Reducing Surgeries Result in ‘Fewer Breast Cancer Events’ for BRCA CarriersDecember 23rd, 2024
  • Merck-AstraZeneca Breast Cancer Drug Reduces Risk of Death by 28% in Patients Diagnosed Early, Clinical Trial Shows
    Merck-AstraZeneca Breast Cancer Drug Reduces Risk of Death by 28% in Patients Diagnosed Early, Clinical Trial ShowsDecember 21st, 2024
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: